Share price
$3.59
As of Apr 29, 2026
LABT | NASDAQ
Lakewood-Amedex Biotherapeutics Inc.
Lakewood-Amedex Biotherapeutics Inc. (LABT) | runway under review | financing risk moderate | market cap $54.5M. Daily snapshot of financials, capital pressu...
Company websiteLast updated Apr 29, 2026
Market cap
$54.5M
Snapshot valuation
30D volume
1.3M shares
Rolling average daily volume
Runway
Runway unresolved
Estimated from precomputed burn and cash
Financing risk
N/A
Financing risk is present, but the current picture is not yet acute.
Snapshot summary
Runway: not fully resolved from the current filing set.
Recent financing detected on Apr 22, 2026.
Financing signal: Financing risk is present, but the current picture is not yet acute.
Recent developments
Lakewood-Amedex Biotherapeutics Inc. 8-K 2026-04-28
8-K filed on 2026-04-28.
Lakewood-Amedex Biotherapeutics Inc. 424B4 2026-04-23
424B4 filing submitted on 2026-04-23.
Lakewood-Amedex Biotherapeutics Inc. S-1/A 2026-04-06
S-1/A filing submitted on 2026-04-06.
Lakewood-Amedex Biotherapeutics Inc. S-1/A 2026-04-01
S-1/A filing submitted on 2026-04-01.
Lakewood-Amedex Biotherapeutics Inc. S-1/A 2026-03-11
S-1/A filing submitted on 2026-03-11.
Related screens
Low cash runway companies
Companies screening with the shortest estimated runway based on precomputed burn and cash snapshots.
High burn rate companies
Companies with the highest estimated trailing cash burn across the monitored issuer set.
Recent financing disclosures
Companies with recent financing activity, capital raises, or post-balance-sheet funding events.
Pre-market filings
Companies with recent filings or disclosures posted before the market open.
Related companies
Recent documents
Lakewood-Amedex Biotherapeutics Inc. 8-K 2026-04-28
8-K filed on 2026-04-28.
Apr 27, 2026Open source
Lakewood-Amedex Biotherapeutics Inc. 424B4 2026-04-23
424B4 filing submitted on 2026-04-23.
Apr 22, 2026Open source
Lakewood-Amedex Biotherapeutics Inc. S-1/A 2026-04-06
S-1/A filing submitted on 2026-04-06.
Apr 5, 2026Open source
Lakewood-Amedex Biotherapeutics Inc. S-1/A 2026-04-01
S-1/A filing submitted on 2026-04-01.
Mar 31, 2026Open source
Premium analysis
Full filing analysis and proprietary signal detail
Detailed impact scoring, historical financial trends, full filing analysis, premium alerts, and proprietary signal explanations stay behind login and subscription.
Full filing analysis with event-level impact scoring
Historical financial trends and runway context
Detailed signal breakdowns and proprietary explanations
Premium alerts, filters, and watchlist workflows
Deeper financing and dilution analysis
Timeline context across filings and disclosures